Flemming Ornskov
19 results

Shire sells cancer drugs to Servier for $2.4bn as Takeda circles
- Health & Pharma
- April 16, 2018, 10:36
Shire, the Irish rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to (...)

Pharma group Shire signs training deal for Dublin
- Health & Pharma
- March 26, 2018, 18:29
Shire, the Ireland-domiciled pharma group that specialises in rare diseases, has signed a training deal with the National Institute of Bioprocessing R(...)

Shire may spin off ADHD drugs business
- Health & Pharma
- August 3, 2017, 14:02
Irish headquartered pharmaceutical company Shire said it was exploring options for its hyperactive drugs business, including a possible stock market l(...)

Dublin-based Shire Pharmaceuticals sees earnings rise 14%
- Health & Pharma
- May 2, 2017, 13:20
Earnings at Dublin-headquartered Shire Pharmaceuticals rose 14 per cent year on year during the first quarter of 2017 due to higher sales of rare dise(...)

Shire receives planning permission for Co Meath plant
- Health & Pharma
- December 6, 2016, 11:10
Pharma giant Shire has received formal planning permission for its new $400 million (€371 million)biologics manufacturing facility on a 120 acre site (...)

Shire shares surge as drug group upgrades earnings guidance
- Health & Pharma
- August 2, 2016, 17:42
Drugmaker Shire said the $32 billion takeover of US rival Baxalta will boost earnings and sales this year, sending its stock surging to the highest le(...)

Perils of paying CEOs too much: When shareholders say no
- Personal Finance
- April 26, 2016, 06:00
Chief executives’ outsized pay packages are again coming under scrutiny, following a host of controversial pay awards in recent weeks. A fortnight ago(...)

Pharma group Shire to create 400 jobs in Co Meath
- Health & Pharma
- April 15, 2016, 13:26
Pharma group Shire is create 400 jobs in Co Meath over the next four years as part of a $400 million investment in the Republic. The company said it (...)

Cantillon: Shire takeover of Baxalta fails to impress shareholders
- Health & Pharma
- January 12, 2016, 07:30
Flemming Ornskov had reason to be pleased yesterday. The Shire CEO’s six-month pursuit of rival Baxalta appears finally to have reached a successful c(...)

Shire to buy Dyax for $5.9 bn
- Health & Pharma
- November 2, 2015, 13:18
Dublin-based Shire has agreed to buy Dyax Corp for about $5.9 billion to gain access to the drug developer’s late-stage experimental treatment for a (...)